Abstract
A new alumina matrix composite ceramic material has been thoroughly evaluated and tested for use as an additional material in the total joint replacement area. The US Food and Drug Administration has approved the material for use in ball heads articulating against polyethylene inserts. Its first clinical use in the United States was in June 2000. Since its introduction, more than 65,000 ball heads of the Alumina Matrix Composite have been implanted. To date, no single clinical failure or material related complication has been reported to the manufacturer. The substantial improvement in mechanical properties and the excellent wear behavior even under severe microseparation wear testing serve to make this material a promising new addition to the orthopedic surgical community.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
